Zanamivir impurity F

Get a Price/Quote

MOQ : 1 Kilograms

Zanamivir impurity F Specification

Usage
Zanamivir. Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza.

Molecular Formula
C12H20N4O7

Molecular Weight
332.31 Grams (g)

Melting Point
245 - 255 C.

Purity
98%

Zanamivir impurity F Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Western Europe, Australia, Eastern Europe, Middle East, Central America, Africa, South America, Asia, North America

Main Domestic Market
All India

About Zanamivir impurity F

Zanamivir impurity F Synonym: 1-Amidinopyrazole hydrochloride, 1H-Pyrazole-1-carboxamidine hydrochloride, Praxadine Empirical Formula (Hill Notation): C4H6N4 HClMolecular Weight: 146.58CAS Number: 4023-02-3

FAQs of Zanamivir impurity F:

Q: What is the purity of Zanamivir impurity F?

A: The purity of Zanamivir impurity F is 98%.

Q: What is the molecular formula of Zanamivir impurity F?

A: The molecular formula of Zanamivir impurity F is C12H20N4O7.

Q: What is the molecular weight of Zanamivir impurity F?

A: The molecular weight of Zanamivir impurity F is 332.31 grams (g).

Q: What is the melting point range of Zanamivir impurity F?

A: The melting point range of Zanamivir impurity F is 245 - 255 C.

Q: What is the primary application of Zanamivir impurity F?

A: Zanamivir impurity F is used in relation to Zanamivir, a medication developed to treat and prevent influenza caused by influenza A and B viruses. Zanamivir is a neuraminidase inhibitor.

Tell us about your requirement